IL129555A - Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth - Google Patents

Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth

Info

Publication number
IL129555A
IL129555A IL12955597A IL12955597A IL129555A IL 129555 A IL129555 A IL 129555A IL 12955597 A IL12955597 A IL 12955597A IL 12955597 A IL12955597 A IL 12955597A IL 129555 A IL129555 A IL 129555A
Authority
IL
Israel
Prior art keywords
oxoacetyl
amino acid
pharmaceutical compositions
acid amide
compositions containing
Prior art date
Application number
IL12955597A
Other languages
English (en)
Other versions
IL129555A0 (en
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL129555(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of IL129555A0 publication Critical patent/IL129555A0/xx
Publication of IL129555A publication Critical patent/IL129555A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12955597A 1996-11-13 1997-11-13 Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth IL129555A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth
PCT/US1997/020866 WO1998020891A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (2)

Publication Number Publication Date
IL129555A0 IL129555A0 (en) 2000-02-29
IL129555A true IL129555A (en) 2005-08-31

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12955597A IL129555A (en) 1996-11-13 1997-11-13 Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth

Country Status (32)

Country Link
US (3) US5840736A (enEXAMPLES)
EP (1) EP0946190B1 (enEXAMPLES)
JP (1) JP2001504470A (enEXAMPLES)
KR (1) KR100544451B1 (enEXAMPLES)
CN (1) CN1168442C (enEXAMPLES)
AP (1) AP9901518A0 (enEXAMPLES)
AR (1) AR011278A1 (enEXAMPLES)
AT (1) ATE250424T1 (enEXAMPLES)
AU (1) AU724833B2 (enEXAMPLES)
BG (1) BG64670B1 (enEXAMPLES)
BR (1) BR9712765A (enEXAMPLES)
CA (1) CA2270634A1 (enEXAMPLES)
CO (1) CO4930260A1 (enEXAMPLES)
CZ (1) CZ296058B6 (enEXAMPLES)
DE (1) DE69725169T2 (enEXAMPLES)
DK (1) DK0946190T3 (enEXAMPLES)
EA (1) EA004247B1 (enEXAMPLES)
ES (1) ES2206753T3 (enEXAMPLES)
HU (1) HU226728B1 (enEXAMPLES)
IL (1) IL129555A (enEXAMPLES)
IN (1) IN183740B (enEXAMPLES)
IS (1) IS2057B (enEXAMPLES)
NO (1) NO328030B1 (enEXAMPLES)
NZ (1) NZ335394A (enEXAMPLES)
PL (1) PL190903B1 (enEXAMPLES)
PT (1) PT946190E (enEXAMPLES)
SK (1) SK284535B6 (enEXAMPLES)
TR (1) TR199901034T2 (enEXAMPLES)
TW (1) TW513302B (enEXAMPLES)
UA (1) UA63926C2 (enEXAMPLES)
WO (1) WO1998020891A1 (enEXAMPLES)
ZA (1) ZA9710256B (enEXAMPLES)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
CA2334002A1 (en) 1998-06-03 1999-12-09 Mark H. Norman N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
EA200100149A1 (ru) 1998-07-17 2001-08-27 Агурон Фармасьютикалз, Инк. Соединения, композиции и способы стимуляции роста и удлинения нейронов
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6228872B1 (en) * 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
JP2002531490A (ja) * 1998-12-09 2002-09-24 カイロン コーポレイション 中枢神経系に薬剤を投与するための方法
WO2000040557A1 (en) * 1999-01-08 2000-07-13 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
AU6073300A (en) 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
EP1207882A4 (en) * 1999-07-30 2003-03-19 Vertex Pharma DERIVATIVES OF ACYCLIC AND CYCLIC AMINES
ATE335524T1 (de) * 1999-11-12 2006-09-15 Alcon Inc Verwendung von neurophilin liganden zur behandlung von augenerkrankungen
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) * 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
WO2001046195A1 (en) 1999-12-21 2001-06-28 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US7507799B2 (en) * 2001-05-25 2009-03-24 Cornell Research Foundation, Inc. High affinity ligand for p75 neurotrophin receptor
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
JP2005500270A (ja) * 2001-05-29 2005-01-06 ギルフォード ファーマシュウティカルズ インコーポレイテッド 手術の結果として発生した神経損傷を治療するための方法
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
AU2002363800A1 (en) * 2001-11-13 2003-05-26 Loi Tran Therapeutic agent composition and method of use
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
WO2007088479A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corp. Methods for treating obesity by administering a trkb antagonist
DOP2007000021A (es) * 2006-02-02 2007-08-31 Rinat Neuroscience Corp Procedimientos para tratar pérdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb
CA2672750A1 (en) * 2006-12-20 2008-07-03 Rinat Neuroscience Corporation Trkb agonists for treating autoimmune disorders
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
AU2019271189A1 (en) 2018-05-15 2021-01-07 Lloyd Hung Loi TRAN Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
CN104718162B (zh) * 2012-09-28 2017-11-21 Dic株式会社 α‑氧化铝微粒以及其制造方法

Also Published As

Publication number Publication date
BG103429A (en) 2000-04-28
AP9901518A0 (en) 1999-06-30
TR199901034T2 (xx) 1999-07-21
ES2206753T3 (es) 2004-05-16
HU226728B1 (en) 2009-08-28
PT946190E (pt) 2004-02-27
IS5032A (is) 1999-04-21
KR20000068962A (ko) 2000-11-25
US6172086B1 (en) 2001-01-09
BR9712765A (pt) 1999-10-26
NZ335394A (en) 2000-06-23
CZ168399A3 (cs) 1999-08-11
JP2001504470A (ja) 2001-04-03
HUP0001219A2 (hu) 2000-11-28
DK0946190T3 (da) 2003-12-08
BG64670B1 (bg) 2005-11-30
EP0946190B1 (en) 2003-09-24
CN1168442C (zh) 2004-09-29
US5840736A (en) 1998-11-24
CN1239433A (zh) 1999-12-22
CO4930260A1 (es) 2000-06-27
CA2270634A1 (en) 1998-05-22
HUP0001219A3 (en) 2001-12-28
PL190903B1 (pl) 2006-02-28
SK284535B6 (sk) 2005-06-02
KR100544451B1 (ko) 2006-01-24
SK62899A3 (en) 2000-04-10
US6284778B1 (en) 2001-09-04
EP0946190A1 (en) 1999-10-06
DE69725169D1 (de) 2003-10-30
EA004247B1 (ru) 2004-02-26
DE69725169T2 (de) 2004-07-15
CZ296058B6 (cs) 2006-01-11
IS2057B (is) 2005-10-14
AU5258998A (en) 1998-06-03
NO328030B1 (no) 2009-11-16
NO992138D0 (no) 1999-05-03
IN183740B (enEXAMPLES) 2000-04-01
NO992138L (no) 1999-07-13
AU724833B2 (en) 2000-09-28
IL129555A0 (en) 2000-02-29
HK1022851A1 (en) 2000-08-25
EA199900464A1 (ru) 2000-02-28
ATE250424T1 (de) 2003-10-15
UA63926C2 (uk) 2004-02-16
WO1998020891A1 (en) 1998-05-22
TW513302B (en) 2002-12-11
ZA9710256B (en) 1998-05-28
PL333270A1 (en) 1999-11-22
AR011278A1 (es) 2000-08-16

Similar Documents

Publication Publication Date Title
IL129555A (en) Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth
HUP9902136A3 (en) Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
IL113625A0 (en) Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use
HUP9601285A3 (en) Substituted n-(indole-2-carbonyl)-beta-alaninamides and derivatives and pharmaceutical compositions containing them
SI1032555T1 (sl) Ciklicne aminokisline in njihovi derivati, uporabni kot farmacevtska sredstva
IL115685A (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0001383A3 (en) N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use
HUP0000492A3 (en) N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HUP9802417A3 (en) Amide derivatives containing heteroaryl group and pharmaceutical compositions containing them
PL323627A1 (en) Alternation of amino acid composition of seeds
HUP0201787A2 (en) Amide derivatives substituted by heterocyclic group useful as growth hormone secretagogues, pharmaceutical compositions containing them
HUP0002404A3 (en) Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
PL339211A1 (en) Basic salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartil]-l-phenylamine 1-methyl ester
IL113329A (en) Pharmaceutical compositions containing n-substituted benzamides
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
PL339207A1 (en) Acid salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartil]-l-phenylamine 1-methyl ester
HUP0104122A3 (en) N-arylsulfonyl amino acid omega amides, process for preparation of the compounds and pharmaceutical compositions containing them
HUP0200116A3 (en) Amide compounds for the potentiation of cholinergic activity and pharmaceutical compositions containing them and process for the preparation of the compounds
HUP9904705A3 (en) N-substituted azaheterocyclic carboxylic acid derivatives and pharmaceutical compositions containing them
IL150037A0 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
FI963440L (fi) Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
FR2766188B1 (fr) Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes
AU6843498A (en) Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees